Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Wave Life Sciences, Inc. - Common Stock (NQ:WVE)

4.755 -0.215 (-4.33%)

Streaming Delayed Price Updated: 1:51 PM EDT, Sep 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,698,543
Open	4.950
Bid (Size)	4.750 (4,000)
Ask (Size)	4.760 (2,500)
Prev. Close	4.970
Today's Range	4.660 - 5.089
52wk Range	4.800 - 21.73
Shares Outstanding	98,983,261
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Wave Life Sciences Announces Completion of Redomiciliation to Delaware

August 10, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware

August 05, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Performance

YTD	-70.2%	-70.2%
1 Month	-17.2%	-17.2%
3 Month	-16.4%	-16.4%
6 Month	-64.6%	-64.6%
1 Year	-50.6%	-50.6%

More News

Wave Life Sciences to Present at Upcoming Investor Conferences

August 04, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript ↗

August 03, 2026

Via The Motley Fool

Wave Life Sciences (NASDAQ:WVE) Plunges After Q2 Revenue Miss ↗

July 30, 2026

Via Chartmill

Wave Life Sciences (NASDAQ:WVE) Beats Q1 Estimates as Obesity Program Accelerates ↗

April 28, 2026

Via Chartmill

Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Via The Motley Fool

WAVE Life Sciences Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

July 30, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026

July 23, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

July 07, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases

June 24, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present at Upcoming Investor Conferences

June 01, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗

May 31, 2026

Via The Motley Fool

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

May 18, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

May 13, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave (WVE) Q1 2026 Earnings Call Transcript ↗

April 29, 2026

Via The Motley Fool

Wave (WVE) Q2 2025 Earnings Call Transcript ↗

April 28, 2026

Via The Motley Fool

Wave (WVE) Q1 2025 Earnings Call Transcript ↗

April 28, 2026

Via The Motley Fool

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

April 28, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Leads Shift Toward Pipeline-Driven Valuation in Biotech Sector

April 22, 2026

Via Investor Brand Network

Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition

April 22, 2026

Via Investor Brand Network

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

April 22, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition

April 22, 2026

From BioMedWire

Via GlobeNewswire

Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States

April 21, 2026

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Wave Life Sciences, Inc. - Common Stock publicly traded?

Yes, Wave Life Sciences, Inc. - Common Stock is publicly traded.

What exchange does Wave Life Sciences, Inc. - Common Stock trade on?

Wave Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Wave Life Sciences, Inc. - Common Stock?

The ticker symbol for Wave Life Sciences, Inc. - Common Stock is WVE on the Nasdaq Stock Market

What is the current price of Wave Life Sciences, Inc. - Common Stock?

The current price of Wave Life Sciences, Inc. - Common Stock is 4.755

When was Wave Life Sciences, Inc. - Common Stock last traded?

The last trade of Wave Life Sciences, Inc. - Common Stock was at 09/02/26 01:51 PM ET

What is the market capitalization of Wave Life Sciences, Inc. - Common Stock?

The market capitalization of Wave Life Sciences, Inc. - Common Stock is 470.67M

How many shares of Wave Life Sciences, Inc. - Common Stock are outstanding?

Wave Life Sciences, Inc. - Common Stock has 471M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.